Is ASIX or CC more profitable?

AdvanSix has a net margin of 0.67% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat AdvanSix's return on equity. Company Net Margins Return on Equity Return on Assets AdvanSix 0.67% 2.18% 1.05% Chemours -6.82% 52.49% 1.78%

Does the media refer more to ASIX or CC?

In the previous week, Chemours had 3 more articles in the media than AdvanSix. MarketBeat recorded 8 mentions for Chemours and 5 mentions for AdvanSix. Chemours' average media sentiment score of 0.74 beat AdvanSix's score of 0.37 indicating that Chemours is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdvanSix 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Chemours 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, CC or DOW?

Chemours has higher earnings, but lower revenue than DOW. DOW is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemours $5.81B 0.43 -$386M -$2.64 N/A DOW $39.97B 0.54 -$2.62B -$1.82 N/A

Is CC or DOW more profitable?

DOW has a net margin of -3.13% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat DOW's return on equity. Company Net Margins Return on Equity Return on Assets Chemours -6.82% 52.49% 1.78% DOW -3.13% 3.26% 0.96%

Does the media prefer CC or DOW?

In the previous week, Chemours had 7 more articles in the media than DOW. MarketBeat recorded 8 mentions for Chemours and 1 mentions for DOW. DOW's average media sentiment score of 1.09 beat Chemours' score of 0.74 indicating that DOW is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DOW 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor EMN or CC?

In the previous week, Eastman Chemical had 9 more articles in the media than Chemours. MarketBeat recorded 17 mentions for Eastman Chemical and 8 mentions for Chemours. Eastman Chemical's average media sentiment score of 1.04 beat Chemours' score of 0.74 indicating that Eastman Chemical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Eastman Chemical 9 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is HUN or CC more profitable?

Huntsman has a net margin of -5.83% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Huntsman's return on equity. Company Net Margins Return on Equity Return on Assets Huntsman -5.83% -4.60% -1.93% Chemours -6.82% 52.49% 1.78%

Does the media refer more to HUN or CC?

In the previous week, Huntsman had 23 more articles in the media than Chemours. MarketBeat recorded 31 mentions for Huntsman and 8 mentions for Chemours. Chemours' average media sentiment score of 0.74 beat Huntsman's score of 0.69 indicating that Chemours is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Huntsman 9 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CC or KRO?

In the previous week, Chemours had 5 more articles in the media than Kronos Worldwide. MarketBeat recorded 8 mentions for Chemours and 3 mentions for Kronos Worldwide. Chemours' average media sentiment score of 0.74 beat Kronos Worldwide's score of 0.00 indicating that Chemours is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kronos Worldwide 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Chemours (CC) Competitors

$16.51 -0.60 (-3.52%)

As of 10:00 AM Eastern

Compare

CC vs. ASIX, DOW, EMN, HUN, and KRO

Should you buy Chemours stock or one of its competitors? MarketBeat compares Chemours with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Chemours include AdvanSix (ASIX), DOW (DOW), Eastman Chemical (EMN), Huntsman (HUN), and Kronos Worldwide (KRO). These companies are all part of the "basic materials" sector.

How does Chemours compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Chemours (NYSE:CC) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

In the previous week, Chemours had 3 more articles in the media than AdvanSix. MarketBeat recorded 8 mentions for Chemours and 5 mentions for AdvanSix. Chemours' average media sentiment score of 0.74 beat AdvanSix's score of 0.37 indicating that Chemours is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdvanSix	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemours	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AdvanSix has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdvanSix	$1.55B	0.35	$49.29M	$0.37	54.24
Chemours	$5.81B	0.43	-$386M	-$2.64	N/A

AdvanSix currently has a consensus price target of $22.50, suggesting a potential upside of 12.11%. Chemours has a consensus price target of $24.10, suggesting a potential upside of 45.99%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than AdvanSix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Chemours	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58

AdvanSix has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market. Comparatively, Chemours has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out -13.3% of its earnings in the form of a dividend. AdvanSix has increased its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

AdvanSix has a net margin of 0.67% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdvanSix	0.67%	2.18%	1.05%
Chemours	-6.82%	52.49%	1.78%

86.4% of AdvanSix shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 5.0% of AdvanSix shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Chemours beats AdvanSix on 12 of the 20 factors compared between the two stocks.

How does Chemours compare to DOW?

Chemours (NYSE:CC) and DOW (NYSE:DOW) are both basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, Chemours had 7 more articles in the media than DOW. MarketBeat recorded 8 mentions for Chemours and 1 mentions for DOW. DOW's average media sentiment score of 1.09 beat Chemours' score of 0.74 indicating that DOW is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DOW	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemours has higher earnings, but lower revenue than DOW. DOW is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.43	-$386M	-$2.64	N/A
DOW	$39.97B	0.54	-$2.62B	-$1.82	N/A

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. DOW pays an annual dividend of $1.40 per share and has a dividend yield of 4.7%. Chemours pays out -13.3% of its earnings in the form of a dividend. DOW pays out -76.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. DOW is clearly the better dividend stock, given its higher yield and lower payout ratio.

Chemours currently has a consensus price target of $24.10, indicating a potential upside of 45.99%. DOW has a consensus price target of $35.56, indicating a potential upside of 19.06%. Given Chemours' stronger consensus rating and higher probable upside, equities research analysts clearly believe Chemours is more favorable than DOW.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58
DOW	2 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.43

DOW has a net margin of -3.13% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat DOW's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-6.82%	52.49%	1.78%
DOW	-3.13%	3.26%	0.96%

76.3% of Chemours shares are held by institutional investors. Comparatively, 64.0% of DOW shares are held by institutional investors. 0.9% of Chemours shares are held by company insiders. Comparatively, 0.5% of DOW shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Chemours has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market. Comparatively, DOW has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

Summary

Chemours beats DOW on 10 of the 18 factors compared between the two stocks.

How does Chemours compare to Eastman Chemical?

Eastman Chemical (NYSE:EMN) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

Eastman Chemical has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, Chemours has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

83.7% of Eastman Chemical shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 2.6% of Eastman Chemical shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Eastman Chemical has a net margin of 4.62% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Eastman Chemical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eastman Chemical	4.62%	8.88%	3.52%
Chemours	-6.82%	52.49%	1.78%

Eastman Chemical has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Eastman Chemical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eastman Chemical	$8.75B	0.90	$474M	$3.45	19.87
Chemours	$5.81B	0.43	-$386M	-$2.64	N/A

In the previous week, Eastman Chemical had 9 more articles in the media than Chemours. MarketBeat recorded 17 mentions for Eastman Chemical and 8 mentions for Chemours. Eastman Chemical's average media sentiment score of 1.04 beat Chemours' score of 0.74 indicating that Eastman Chemical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Eastman Chemical	9 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemours	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Eastman Chemical pays an annual dividend of $3.36 per share and has a dividend yield of 4.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. Eastman Chemical pays out 97.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Chemours pays out -13.3% of its earnings in the form of a dividend. Eastman Chemical has raised its dividend for 15 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Eastman Chemical currently has a consensus price target of $80.50, suggesting a potential upside of 17.43%. Chemours has a consensus price target of $24.10, suggesting a potential upside of 45.99%. Given Chemours' stronger consensus rating and higher probable upside, analysts plainly believe Chemours is more favorable than Eastman Chemical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eastman Chemical	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Chemours	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58

Summary

Eastman Chemical beats Chemours on 14 of the 20 factors compared between the two stocks.

How does Chemours compare to Huntsman?

Huntsman (NYSE:HUN) and Chemours (NYSE:CC) are both basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

In the previous week, Huntsman had 23 more articles in the media than Chemours. MarketBeat recorded 31 mentions for Huntsman and 8 mentions for Chemours. Chemours' average media sentiment score of 0.74 beat Huntsman's score of 0.69 indicating that Chemours is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Huntsman	9 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemours	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Huntsman has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than Huntsman, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Huntsman	$5.68B	0.31	-$284M	-$1.92	N/A
Chemours	$5.81B	0.43	-$386M	-$2.64	N/A

Huntsman has a net margin of -5.83% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Huntsman's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Huntsman	-5.83%	-4.60%	-1.93%
Chemours	-6.82%	52.49%	1.78%

Huntsman has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Chemours has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

Huntsman presently has a consensus price target of $13.67, suggesting a potential upside of 35.78%. Chemours has a consensus price target of $24.10, suggesting a potential upside of 45.99%. Given Chemours' stronger consensus rating and higher probable upside, analysts clearly believe Chemours is more favorable than Huntsman.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Huntsman	3 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00
Chemours	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58

84.8% of Huntsman shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 6.8% of Huntsman shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Huntsman pays an annual dividend of $0.35 per share and has a dividend yield of 3.5%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. Huntsman pays out -18.2% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has increased its dividend for 4 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Huntsman beats Chemours on 10 of the 19 factors compared between the two stocks.

How does Chemours compare to Kronos Worldwide?

Chemours (NYSE:CC) and Kronos Worldwide (NYSE:KRO) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, Chemours had 5 more articles in the media than Kronos Worldwide. MarketBeat recorded 8 mentions for Chemours and 3 mentions for Kronos Worldwide. Chemours' average media sentiment score of 0.74 beat Kronos Worldwide's score of 0.00 indicating that Chemours is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kronos Worldwide	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Chemours has a net margin of -6.82% compared to Kronos Worldwide's net margin of -7.12%. Chemours' return on equity of 52.49% beat Kronos Worldwide's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-6.82%	52.49%	1.78%
Kronos Worldwide	-7.12%	-15.01%	-6.33%

Chemours presently has a consensus target price of $24.10, suggesting a potential upside of 45.99%. Kronos Worldwide has a consensus target price of $5.00, suggesting a potential downside of 17.08%. Given Chemours' stronger consensus rating and higher probable upside, equities analysts plainly believe Chemours is more favorable than Kronos Worldwide.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58
Kronos Worldwide	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.00

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. Kronos Worldwide pays an annual dividend of $0.20 per share and has a dividend yield of 3.3%. Chemours pays out -13.3% of its earnings in the form of a dividend. Kronos Worldwide pays out -17.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Kronos Worldwide is clearly the better dividend stock, given its higher yield and lower payout ratio.

Kronos Worldwide has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Kronos Worldwide, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.43	-$386M	-$2.64	N/A
Kronos Worldwide	$1.88B	0.37	-$110.90M	-$1.16	N/A

76.3% of Chemours shares are owned by institutional investors. Comparatively, 15.1% of Kronos Worldwide shares are owned by institutional investors. 0.9% of Chemours shares are owned by company insiders. Comparatively, 0.2% of Kronos Worldwide shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Chemours has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market. Comparatively, Kronos Worldwide has a beta of 1, meaning that its share price has a similar volatility profile to the broader market.

Summary

Chemours beats Kronos Worldwide on 13 of the 18 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CC vs. The Competition

Export

Metric	Chemours	CHEM Industry	Materials Sector	NYSE Exchange
Market Cap	$2.49B	$12.76B	$4.54B	$23.61B
Dividend Yield	2.12%	2.57%	5.02%	4.19%
P/E Ratio	-6.28	37.10	21.05	30.75
Price / Sales	0.43	1.74	5,390.91	160.06
Price / Cash	5.00	11.63	26.15	31.18
Price / Book	9.89	1.80	8.50	4.62
Net Income	-$386M	$171.68M	$156.37M	$1.07B
7 Day Performance	-4.28%	-1.79%	-0.33%	0.16%
1 Month Performance	-19.60%	-1.24%	-1.57%	1.12%
1 Year Performance	37.97%	25.64%	39.82%	17.16%

Chemours Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CC Chemours	4.6488 of 5 stars	$16.51 -3.5%	$24.10 +46.0%	+36.0%	$2.49B	$5.81B	N/A	5,700	News Coverage Upcoming Earnings
ASIX AdvanSix	3.2527 of 5 stars	$20.25 -3.8%	$22.50 +11.1%	+0.8%	$567.49M	$1.55B	54.73	1,410	News Coverage Upcoming Earnings
DOW DOW	4.0721 of 5 stars	$28.75 -3.6%	$35.56 +23.7%	+25.4%	$21.51B	$39.97B	N/A	34,600	Positive News
EMN Eastman Chemical	4.9491 of 5 stars	$67.64 -0.8%	$80.50 +19.0%	-4.6%	$7.80B	$8.75B	19.60	13,000	Trending News Earnings Report
HUN Huntsman	4.0023 of 5 stars	$11.74 -8.3%	$13.67 +16.4%	+21.3%	$2.24B	$5.68B	N/A	6,000	Trending News Dividend Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CC) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chemours (CC) Competitors